Boston Scientific Corporation (BSX) stock analysis

Healthcare · Medical Devices

From the 10-K filed 2026-02-17

Business type: Franchise

How it makes money

Boston Scientific sells medical devices across diverse interventional specialties, generating sales through hospital and healthcare provider purchases.

Boston Scientific operates as a global developer, manufacturer, and marketer of medical devices designed for various interventional medical specialties. Hospitals, clinics, and physicians purchase these devices as alternatives to traditional, traumatic surgery. Financial performance is primarily driven by procedural volumes, successful new product introductions, and adoption rates across its business units.

What protects it: the moat

The company relies on patents, proprietary technology, and regulatory approvals to protect its market position.

Management asserts that maintaining a competitive edge requires continuous investments in research and development and obtaining intellectual property protection. However, the medical device market is intensely competitive, with numerous players ranging from large diversified manufacturers to specialized single-product companies.

What growth costs

The company continuously reinvests financial resources into research, acquisitions, and commercial execution to drive organic and inorganic growth.

Boston Scientific directs capital toward developing advanced technologies, launching next-generation products, and integrating completed acquisitions. The filing does not provide explicit standalone figures for ongoing maintenance capital expenditures versus growth expenditures.

What could damage it

Delays in next-generation product launches or diminished physician confidence can reduce market share and depress earnings.

If next-generation medical devices face regulatory delays or fail to gain market acceptance, physicians may switch to competitor offerings. Lower procedural adoption directly reduces product demand and top-line revenue.

About Boston Scientific Corporation

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems. The company also provides technologies for diagnosing and treating a range of diseases and abnormalities of the heart; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, it offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose and treat forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

More on BSX

Other companies in Medical Devices